AEON Stock Summary and Trading Ideas (Aeon Biopharma Class A | AMEX:AEON)

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Aeon Biopharma Class A trades on the AMEX stock market under the symbol AEON.

As of December 23, 2025, AEON stock price declined to $1.01 with 130,571 million shares trading.

AEON has a beta of 2.70, meaning it tends to be more sensitive to market movements. AEON has a correlation of 0.03 to the broad based SPY ETF.

AEON has a market cap of $13.94 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that AEON belongs to (by Net Assets): VXF.

AEON has underperformed the market in the last year with a return of -97.8%, while SPY returned +17.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AEON shares. However, AEON has outperformed the market in the last 3 month and 2 week periods, returning +31.4% and +32.9%, while SPY returned +3.5% and +0.9%, respectively. This indicates AEON has been having a stronger performance recently.

AEON support price is $.96 and resistance is $1.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEON shares will trade within this expected range on the day.